Ascites: all 259 studies
Page 2 of 3. Open to participants first (52), then studies with results posted, then the rest; newest registration first within each.
- Empagliflozin in Diuretic Refractory AscitesCompletedNCT05013502Phase 1
- Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to DrugsWithdrawnNCT04985357
- Evaluation of Albumin and Midodrine Versus Albumin Alone in Outcome of Refractory Ascites in Patients With Decompensated Cirrhosis.Status unknownNCT04816240Not applicable
- Effects of Adding Hypertonic Saline Solutions and/or Etilefrine to Standard Diuretics Therapy in Hepatic AscitesCompletedNCT04785755Phase 2
- Intraperitoneal Injection of Oncolytic Viruses H101 for Patients With Refractory Malignant AscitesCompletedNCT04771676Phase 2
- Phase Ib of Recombinant Human Albumin InjectionCompletedNCT04701697Phase 1
- Efficacy of Targeted And Response-Guided Albumin Therapy Versus Standard Medical Treatment In Outcomes Of Recurrent Ascites In Patients With Decompensated Cirrhosis.Status unknownNCT04679571Not applicable
- Non-Pharmaceutical Intervention for Cirrhotic Cramps Reduction: The NICCles TrialCompletedNCT04650295Not applicable
- Safety and Tolerance Study of Recombinant Human Albumin Injection in Healthy Subjects.CompletedNCT04641364Phase 1
- TIPS Combined With Microwave Ablation in HCC Patients With Refractory AscitesStatus unknownNCT04640116Not applicable
- Midodrine and Albumin in Patients With Refractory AscitesStatus unknownNCT04621617Phase 3
- Prospective Evaluation of PleurX Drain for Treatment of Cirrhotic Refractory AscitesCompletedNCT04569565Not applicable
- Role Of Multi-detector Computed Tomography In Differentiation Between Different Types Of AscitesStatus unknownNCT04550091
- Immune Checkpoints in Intraabdominal Ascites FluidCompletedNCT04540159
- Investigating Signal Change in Malignant and Non-malignant Pleural Effusions and asCitic Fluid Using fTiR AnalysisCompletedNCT04533854
- Safety and Efficacy of Small Frequent Paracentesis Using an Indwelling CAtheter Compared With Repeated Large Volume Paracentesis in Cirrhotic Patients With REfractory AscitesStatus unknownNCT04406298Not applicable
- International Alfapump Cohort StudyActive, not recruitingNCT04326946
- Continuous Passive Paracentesis for Intra-abdominal HypertensionStatus unknownNCT04322201Not applicable
- Comparing Ascites Relief In Two Standard Treatments: Large Volume Paracentesis Vs. Early Tips Using Viatorr Controlled Expansion StentsCompletedNCT04315571Not applicable
- Refractory Ascites in Patients With Liver Cirrhosis, and the Potential Treatment With 48 Hours Infusion of Ularitide.TerminatedNCT04311489Phase 2
- Cell Block Immunohistochemistry in Effusion CytologyStatus unknownNCT04279327
- Does Point of Care Ultrasound Change Needle Insertion Location During Routine Bedside Paracentesis?CompletedNCT04245553Not applicable
- Comparison of "Roll-over' Technique With Standard Abdominal Paracentesis in Suspected Peritoneal CarcinomatosisTerminatedNCT04232384Not applicable
- The Effect of Terlipressin on Recovery of Liver Function After HepatectomyStatus unknownNCT04221672Phase 3
- Efficacy of Combination of Midodrine With Propranolol in Preventing First Bleed in Decompensated Cirrhotics With Severe Ascites.CompletedNCT04208776Not applicable
- Effect of Ascites Replacement Strategy on Time to 1st Flatus After LDLTCompletedNCT04184401Phase 4
- Application of Clinical Metagenomics in the Diagnosis of AscitesCompletedNCT04131751
- Metagenomic Next-Generation Sequencing for Diagnosis of Ascites Infection in End-stage Liver DiseasesStatus unknownNCT04125654Not applicable
- A Study for Evaluation of BIV201 to Reduce Ascites and Complications in Patients With Cirrhosis and Refractory AscitesTerminatedNCT04112199Phase 2
- Fresh Frozen Plasma as a Substitute for Albumin in Patients Receiving a Large Volume ParacentesisWithdrawnNCT04109144Phase 2
- Malignant Ascites Alfapump® StudyWithdrawnNCT04076566
- Effects of Maintaining Steady Albumin Levels (TAT 4) on Survival and Liver Related Complications in Cirrhosis With AscitesStatus unknownNCT04058613Not applicable
- Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant AscitesCompletedNCT04051112Phase 1
- Evaluation of Hemodynamic Parameters Following Transjugular Intrahepatic Portosystemic Shunt (TIPS)CompletedNCT04050683Not applicable
- Safety and Efficacy of Midodrine Hydrochloride in the Management of Refractory Ascites Due to Cirrhosis in ChildrenStatus unknownNCT04043858Not applicable
- Malignant Ascites in Ovarian Cancer: Impact of Total Paracentesis on HemodynamicsCompletedNCT04032600Not applicable
- Efficacy and Safety of Early TIPS (Transjugular Intrahepatic Portosystemic Shunts) in the Management of Cirrhosis With Recurrent Ascites.Status unknownNCT04013074Not applicable
- S1+ Paclitaxel (IV&IP) + Bevacizumab (IP) Versus S1+Oxaliplatin as First-line Treatment in Gastric Cancer With Malignant AscitesStatus unknownNCT03990103Phase 2
- Alfapump® System in the Treatment of Refractory or Recurrent Ascites (POSEIDON Study)Status unknownNCT03973866Not applicable
- A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver CirrhosisTerminatedNCT03827200Phase 2
- A Study of Syngenon (BSG-001) for Inhalation in Subjects With Malignant Pleural Effusion and/or Malignant AscitesStatus unknownNCT03736122Phase 1/2
- CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC)WithdrawnNCT03682744Phase 1
- Quality of Life of Patients Who Have Rocket Indwelling Pleural Catheter Drainage or Repeated Large Volume ParacentesisStatus unknownNCT03550690
- EUS-Guided Drainage of Refractory Malignant AscitesStatus unknownNCT03550560
- Tackling 30-day Readmissions in Patients With Cirrhosis: The SALTYFOOD TrialCompletedNCT03493204Not applicable
- A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant AscitesStatus unknownNCT03475615Phase 3
- Serum-Ascites Albumin Gradient Analysis in Cancer Patients in Palliative CareStatus unknownNCT03463655
- Outcome After TIPSCompletedNCT03459378
- Diagnosis of Ascites in Infants and ChildrenStatus unknownNCT03341221
- Point-of-care Ultrasound in FinlandCompletedNCT03327688Not applicable
- Evaluation of Copeptin in Patients With Cirrhosis and AscitesCompletedNCT03318601Not applicable
- Validation of Diagnostic Usefulness of the Random Urine Na/K Ratio for Replacement of 24hr Urine Na Excretion in Cirrhotic Patients With AscitesCompletedNCT03263598
- Clinical Study of Autologous Erythrocytes Derived MPs Packaging MTX Peritoneal Perfusion to Treat Malignant AscitesStatus unknownNCT03230708Phase 1/2
- International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)Status unknownNCT03210298
- Evaluation of Different Etiologies of Obscure AscitesStatus unknownNCT03205748
- Fresh Frozen Plasma as a Substitute for Albumin in Patients Receiving a Large Volume ParacentesisWithdrawnNCT03202524Phase 4
- Retrospective Study in the Use of the Alfapump and the Treatment of Malignant AscitesCompletedNCT03200106
- Evaluation of 'Melody' Paracentesis Device for Ascites TherapyCompletedNCT03191851Not applicable
- Early Use of TIPS With Polytetrafluoroethylene(PTFE) Covered Stents in Cirrhotic Patients With Refractory AscitesStatus unknownNCT03172273Not applicable
- Two Strategies of Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Severe Cirrhotic Patients With AscitesCompletedNCT03069131Phase 3
- PEriToneal Catheter Versus Repeated Paracentesis for Ascites in CirrhosisTerminatedNCT03027635Not applicable
- Acute Hemodynamic Changes During ParacentesisCompletedNCT02996188
- Peritoneal Dialysis Catheters for the Treatment of Refractory AscitesCompletedNCT02975726Not applicable
- Bedside Inoculation of Ascitic Fluid in Diagnostic ParacentesisWithdrawnNCT02895919
- Liquid Biopsy With Immunomagnetic Beads Capture Technique for Malignant Cell Detection in Body FluidStatus unknownNCT02891642
- Analysis of Patients Treated With Bevacizumab Intraperitoneal for the Treatment of Refractory Malignant AscitesCompletedNCT02891369
- Impact Of Timing Of Drainage Of Massive Ascites On Operative And Post-Operative Course In Living-Donor Liver Transplant Recipients. A Prospective Randomized Controlled Trial.CompletedNCT02867293Not applicable
- Calprotectin for Rapid Diagnostic Infection Spontaneous of AscitesStatus unknownNCT02857101
- Metabolic Effects of Furosemide +HSS in Refractory AscitesCompletedNCT02821377Phase 2
- Refractory Ascitis Diagnosis by the Study of Labelled Albumin PharmacokineticsStatus unknownNCT02818673Phase 3
- The Role of Intravenous Albumin Replacement During Abdominal Paracentesis in Patients With Malignancy Related AscitesStatus unknownNCT02811406Not applicable
- Evaluation of Postoperative Ascites After Somatostatin Infusion Following Hepatectomy for Hepatocellular CarcinomaCompletedNCT02799212Phase 3
- Abdominal Hernia in Cirrhotic Patients: Surgery or Conservative Treatment?CompletedNCT02787772Not applicable
- The Study of Intraperitoneal Docetaxel Plus S-1 for Malignant AscitesStatus unknownNCT02779608Phase 2
- The Effect of Branched-chain Amino Acid on the Improvement of Serum Albumin Level in Cirrhotic Patients With AscitesStatus unknownNCT02755701Phase 4
- Preoperative Ascites Drainage Versus Standard Care for Patients With Advanced Ovarian CancerSuspendedNCT02742428Not applicable
- Symptomatic Ascites Drainage With a Patient-controlled Vascular Catheter.Status unknownNCT02724683
- To Study the Effect of Nonselective Beta Blockers in Advanced Stage Liver Disease With AscitesCompletedNCT02649335Phase 3
- Alfapump System Versus Transjugular Intrahepatic Portosystemic Shunt and Paracentesis in the Treatment of AscitesTerminatedNCT02612519Not applicable
- Evaluation of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With Decompensated Cirrhosis With AscitesCompletedNCT02608658Not applicable
- A Tolerance Trial of Cinobufacini Injection Intraperitoneal Perfusion on Digestive System Cancer With AscitesStatus unknownNCT02530398Phase 1
- Evaluation of the Efficacy of Diuretics for Symptomatic Malignant Ascites Episodes in Advanced Stage of Cancer (DIASC)TerminatedNCT02501213Phase 2
- Feasibility Study of Intraperitoneal Bevacizumab for Palliation of Intractable Malignant AscitesTerminatedNCT02496286Phase 1
- Palliative Care Outcomes in the Management of Malignant Ascites by Interventional RadiologyWithdrawnNCT02477657
- To Study and Compare the Clinical Course and Development of Organ Failure in Severe Acute Hepatitis Without Ascites, Non-cirrhotic and Cirrhotic Patients With Ascites [Acute on Chronic Liver Failure] and Acute Deterioration of Previously Decompensated Cirrhosis.WithdrawnNCT02465619
- Lean Mass Evaluation of Cirrhotic Patients With Ascites With the Use DXACompletedNCT02421848
- A (M)Ulti-center, Prospective, (O)Pen Label, Uncontrolled Feasibility (S)Tudy to Assess the Safety and Effectiveness of an Automatic Low Flow (A)Scites (Alfa) Pump (I)n Patients With (C)Irrhosis and Refractory or Recurrent AscitesCompletedNCT02400164Not applicable
- Role of Midodrine and Tolvaptan in Patients With Cirrhosis With Refractory or Recurrent AscitesCompletedNCT02173288Phase 2/3
- Effect of Beta-adrenergic Blockers on Cardiac Function, Systemic and Splanchnic Haemodynamic and Kidney Function in Cirrhotic Patiets With Refractory AscitesCompletedNCT02163512
- Comparative Study of Rifaximin Versus Norfloxacin in the Secondary Prophylaxis of Spontaneous Bacterial PeritonitisStatus unknownNCT02120196Phase 3
- Glutamine Challenge as Predictor of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS)TerminatedNCT02026609
- Body Composition Analysis in Cirrhotic Undergoing ParacentesisStatus unknownNCT02022150
- Safety and Effectiveness Study of Tumor Cell-derived Microparticles to Treat Malignant Ascites and Pleural EffusionStatus unknownNCT01854866Phase 2
- Autologous Mesenchymal Stem Cell Transplantation in Cirrhosis Patients With Refractory AscitesStatus unknownNCT01854125Phase 3
- Phase I Trial of Intraperitoneal Bevacizumab in Refractory Malignant AscitesStatus unknownNCT01852409Phase 1
- Clinical Study in Treatment of Malignant Ascites of Ovarian Cancer With Intraperitoneal Injection Bevacizumab Combined With Intraperitoneal Hyperthermic Perfusion ChemotherapyStatus unknownNCT01838538Phase 2
- Eplerenone Versus Spironolactone as Treatment of Ascites Due to Liver Cirrhosis; a Study of Efficacy and Side EffectsWithdrawnNCT01801228Phase 2
- The Effect of a Large-volume Paracentesis on Fatigue, Sleep, and Quality of Life in CirrhosisWithdrawnNCT01777971
- Intestinal Decontamination With Rifaximin. The Inflammatory and Circulatory State in Patients With CirrhosisCompletedNCT01769040Phase 4
- Tolvaptan for Hyponatremia in Cirrhotic Patients With AscitesStatus unknownNCT01716611Phase 4